King's College London

Research portal

Research Outputs

  1. 2014
  2. Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial

    Platzbecker, U., Sekeres, M. A., Kantarjian, H., Giagounidis, A., Mufti, G. J., Jia, C., Yang, A. S. & Fenaux, P., Dec 2014, In : Leukemia. 28, 12, p. 2418-2421 4 p.

    Research output: Contribution to journalLetter

  3. Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: implications for a possible immunomodulatory role

    Bart-Smith, E. E., Kordasti, S., Kulasekararaj, A. G., Richardson, D., Mufti, G. J. & Marsh, J. C. W., 28 Nov 2014, In : Aids. 28, 18, p. 2786-2788 3 p.

    Research output: Contribution to journalLetter

  4. Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies

    Feliu, J., Clay, J., Raj, K., Barber, L., Devlia, V., Shaw, B., Pagliuca, T. & Mufti, G., Nov 2014, In : British Journal of Haematology. 167, 3, p. 426-428 3 p.

    Research output: Contribution to journalLetter

  5. Re: Hinata et al.: Novel Telementoring System for Robot-assisted Radical Prostatectomy: Impact on the Learning Curve. (Urology 2014;83:1088-92)

    Yu, A. W., Abboudi, H., Shamim Khan, M., Dasgupta, P. & Ahmed, K., Oct 2014, In : Urology. 84, 4, p. 987-987 1 p.

    Research output: Contribution to journalLetter

  6. Guidelines for the diagnosis and management of adult myelodysplastic syndromes

    Killick, S. B., Carter, C., Culligan, D., Dalley, C., Das-Gupta, E., Drummond, M., Enright, H., Jones, G. L., Kell, J., Mills, J., Mufti, G., Parker, J., Raj, K., Sternberg, A., Vyas, P., Bowen, D. & British Comm Stand Haematol, Feb 2014, In : British Journal of Haematology. 164, 4, p. 503-525 23 p.

    Research output: Contribution to journalLetter

  7. 2013
  8. Mitoxanthrone-induced acute myeloid leukaemia presenting with leukaemia cutis

    Fleming, J. D., Walsh, S., Salisbury, J., Du-Vivier, A. W. P. & Mufti, G., May 2013, In : European Journal of Dermatology. 23, 3, p. 419-420 2 p.

    Research output: Contribution to journalLetter

  9. 2012
  10. Focal HIFU for prostate cancer

    Challacombe, B., Dasgupta, P., Kirby, R., Fitzpatrick, J. & Catalona, W., Jul 2012, In : The Lancet Oncology. 13, 7, p. E283-E284 2 p.

    Research output: Contribution to journalLetter

  11. Reply. Are we producing competent and technology-attentive urologists?

    Ahmed, K., Gohil, R., Khan, R. S., Kumar, P., Challacombe, B., Khan, M. S. & Dasgupta, P., 1 Mar 2012, In : BJU International. 109, 5

    Research output: Contribution to journalLetter

  12. 2011
  13. Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris

    Craythorne, E. E., Mufti, G. & duVivier, A. W., Nov 2011, In : Journal of the American Academy of Dermatology. 65, 5, p. 1064-1065 2 p.

    Research output: Contribution to journalLetter

  14. Erythropoietic Uroporphyria Associated with Myeloid Malignancy Is Likely Distinct from Autosomal Recessive Congenital Erythropoietic Porphyria

    Sarkany, R. P. E., Ibbotson, S. H., Whatley, S. D., Lawrence, C. M., Gover, P., Mufti, G. J., Murphy, G. M., Masters, G. S., Badminton, M. N. & Elder, G. H., May 2011, In : Journal of Investigative Dermatology. 131, 5, p. 1172 - 1175 4 p.

    Research output: Contribution to journalLetter

  15. 2010
  16. Mucous membrane pemphigoid following reduced intensity conditioning allogeneic haematopoietic SCT for biphenotypic leukaemia

    Mahmood, S., Lim, Z. Y., Benton, E., du Vivier, A., Bhogal, B., Mufti, G. J. & Pagliuca, A., Jan 2010, In : Bone Marrow Transplantation. 45, 1, p. 195 - 196 2 p.

    Research output: Contribution to journalLetter

  17. 2009
  18. Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients

    Mohamedali, A., Guinn, B., Sahu, S., Thomas, N. S. & Mufti, G. J., Jan 2009, In : British Journal of Haematology. 144, 2, p. 263 - 265 3 p.

    Research output: Contribution to journalLetter

  19. 2008
  20. Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease

    Lim, Z. Y., Ho, A. Y. L., Abrahams, S., Fensom, A., Aldouri, M., Pagliuca, A., Shaw, C. & Mufti, G. J., May 2008, In : Bone Marrow Transplantation. 41, 9, p. 831 - 832 2 p.

    Research output: Contribution to journalLetter

  21. Tumor-derived IL-6 may contribute to the immunological defect in CLL

    Buggins, A. G. S., Patten, P., Richards, J., Thomas, N. S. B., Mufti, G. J. & Devereux, S., May 2008, In : Leukemia. 22, 5, p. 1084-1087 4 p.

    Research output: Contribution to journalLetter

  22. Sarcoidosis and haematological malignancies: is there an association?

    Gooneratne, L., Nagi, W., Lim, Z., Ho, A. Y. L., Devereux, S., Pagliuca, A. & Mufti, G. J., Apr 2008, In : British Journal of Haematology. 141, 2, p. 260 - 262 3 p.

    Research output: Contribution to journalLetter

  23. Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases maybe more informative

    Lim, Z. Y., Pearce, L., Ingram, W., Ho, A. Y. L., Mufti, G. J. & Pagliuca, A., Mar 2008, In : Bone Marrow Transplantation. 41, 6, p. 587 - 588 2 p.

    Research output: Contribution to journalLetter

  24. Leucoderma and leucotrichia in association with chronic cutaneous graft-versus-host disease

    Williams, J. S., Mufti, G. J., Du Vivier, A. W. P., Salisbury, J. R. & Creamer, D., Jan 2008, In : British Journal of Dermatology. 158, 1, p. 172 - 174 3 p.

    Research output: Contribution to journalLetter

  25. Mixed donor chimaerism in recipient fingernails following reduced-intensity conditioning haematopoietic SCT

    Pearce, L., Lim, Z. Y., Usai, M., Ho, A. Y. L., Mufti, G. & Pagliuca, A., 2008, In : Bone Marrow Transplantation. 42, 5, p. 361 - 362 2 p.

    Research output: Contribution to journalLetter

  26. 2007
  27. Acquired factor V inhibitor after haematopoietic stem cell transplantation

    Milojkovic, D., Patel, R., Ford, E., Arya, R. & Mufti, G., Sep 2007, In : Thrombosis and Haemostasis. 98, 3, p. 685 - 686 2 p.

    Research output: Contribution to journalLetter

  28. The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells

    Denniss, F., Breslin, A., Ingram, W., Hardwick, N., Mufti, G. & Guinn, B. A., Sep 2007, In : British Journal of Haematology. 138, 5, p. 668 - 669 2 p.

    Research output: Contribution to journalLetter

  29. False positive results of galactomannan ELISA assay in haemato-oncology patients: A single centre experience

    Lim, Z. Y., Ho, A. Y. L., Devereux, S., Mufti, G. J., Pagliuca, A., Wade, J. & Smith, M., Aug 2007, In : Journal of Infection. 55, 2, p. 201 - 202 2 p.

    Research output: Contribution to journalLetter

  30. JAK V617F missense mutation is absent in pancreatic cancer

    Kocher, H. M., Mears, L., Lea, N. C., Raj, K. & Mufti, G. J., Aug 2007, In : Gut. 56, 8, p. 1174 - 1175 2 p.

    Research output: Contribution to journalLetter

  31. Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy

    Ramasamy, K., Hayden, J., Lim, Z., Mufti, G. J. & Ho, A. Y. L., May 2007, In : British Journal of Haematology. 137, 4, p. 374 - 375 2 p.

    Research output: Contribution to journalLetter

  32. Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantation

    Gooneratne, L., Lim, Z. Y., du Vivier, A., Salisbury, J. R., Knisely, A. S., Ho, A. Y. L., Pagliuca, A. & Mufti, G. J., Apr 2007, In : Bone Marrow Transplantation. 39, 8, p. 511 - 512 2 p.

    Research output: Contribution to journalLetter

  33. Botulinum toxin a in the overactive bladder: Current status and future directions

    Mallina, R., Sahai, A., Khan, M. S. & Dasgupta, P., 2007, In : BJU International. 99, 6, p. 1549 - 1550 2 p.

    Research output: Contribution to journalLetter

  34. Informed consent: Are we deluding ourselves? A randomized controlled study - Reply

    Sahai, A., Murphy, D. & Dasgupta, P., 2007, In : BJU International. 99, 4, p. 943 - 943 1 p.

    Research output: Contribution to journalLetter

  35. 2006
  36. Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)

    Ramasamy, K., Lim, Z. Y., Pagliuca, A., Grundy, R., Devereux, S., Ho, A. Y. L. & Mufti, G. J., Dec 2006, In : Bone Marrow Transplantation. 38, 12, p. 823 - 824 2 p.

    Research output: Contribution to journalLetter

  37. The JAK2 V617F mutation is rare in RARS but common in RARS-T

    Ceesay, M. M., Lea, N. C., Ingram, W., Westwood, N. B., Gaken, J., Mohamedali, A., Cervera, J., Germing, U., Gallermann, N., Giagounidis, A., Garcia-Casado, Z., Sanz, G. & Mufti, G. J., Nov 2006, In : Leukemia. 20, 11, p. 2060 - 2061 2 p.

    Research output: Contribution to journalLetter

  38. Disseminated herpes virus (HSV-2) infection with rhabdomyolysis and hemophagocytic lymphohistiocytosis in a patient with bone marrow failure syndrome

    Ramasamy, K., Lim, Z. Y., Savvas, M., Salisbury, J. R., Dokal, I., Mufti, G. J. & Pagliuca, A., Sep 2006, In : Annals of Hematology. 85, 9, p. 629 - 630 2 p.

    Research output: Contribution to journalLetter

  39. Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy

    Milojkovic, D., Aldouri, M., Pagliuca, A., Mufti, G. J. & Devereux, S., Sep 2006, In : Bone Marrow Transplantation. 38, 6, p. 461 - 462 2 p.

    Research output: Contribution to journalLetter

  40. High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders

    Bowcock, S. J., Rassam, S. M. B., Lim, Z., Ward, S. M., Ryali, M. M. & Mufti, G. J., Jul 2006, In : British Journal of Haematology. 134, 2, p. 242 - 243 2 p.

    Research output: Contribution to journalLetter

  41. Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia

    Lea, N. C., Lim, Z., Westwood, N. B., Arno, M. J., Gaken, J., Mohamedali, A. & Mufti, G. J., Jul 2006, In : Leukemia. 20, 7, p. 1324 - 1326 3 p.

    Research output: Contribution to journalLetter

  42. The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

    Ingram, W., Lea, N. C., Cervera, J., Germing, U., Fenaux, P., Cassinat, B., Kiladjian, J. J., Varkonyi, J., Antunovic, P., Westwood, N. B., Arno, M. J., Mohamedali, A., Gaken, J., Kontou, T., Czepulkowski, B. H., Twine, N. A., Tamaska, J., Csomer, J., Benedek, S., Gattermann, N. & 5 others, Zipperer, E., Giagounidis, A., Garcia-Casado, Z., Sanz, G. & Mufti, G. J., Jul 2006, In : Leukemia. 20, 7, p. 1319 - 1321 3 p.

    Research output: Contribution to journalLetter

  43. The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia

    Guinn, B. A., Gilkes, A. F., Mufti, G. J., Burnett, A. K. & Mills, K. I., Jul 2006, In : British Journal of Haematology. 134, 2, p. 238 - 239 2 p.

    Research output: Contribution to journalLetter

  44. Mobilization of hematopoietic progenitors in low-grade myelodysplastic syndromes

    Mijovic, A., Delforge, M., Sekhavat, M., Czepulkowski, B. & Mufti, G. J., Apr 2006, In : Haematologica. 91, 4, p. 572 - 573 2 p.

    Research output: Contribution to journalLetter

  45. Reduced-intensity conditioned allogeneic haematopoietic transplantation in an adult with Langerhans cell histiocytosis and thrombocytopenia with absent radii

    Ingram, W., Desai, S. R., Gibbs, J. S. R. & Mufti, G., Apr 2006, In : Bone Marrow Transplantation. 37, 7, p. 713 - 715 3 p.

    Research output: Contribution to journalLetter

  46. 2005
  47. Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently

    Milojkovic, D., Buggins, A. G. S., Devereux, S., Thomas, N. S. B. & Mufti, G., Sep 2005, In : Leukemia. 19, 9, p. 1699 - 1702 4 p.

    Research output: Contribution to journalLetter

  48. Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation

    Mijovic, A., Russell, N., Clark, R. E., Morris, T. C. M., Browne, P., Crown, J., Potter, M. & Mufti, G. J., May 2005, In : Bone Marrow Transplantation. 35, 10, p. 1019 - 1019 1 p.

    Research output: Contribution to journalLetter

  49. The effect of interleukin-7 on the alloreactivity of human T cells depends on the timing of its administration in relation to the allostimulus

    Duarte, R. F., Mufti, G. J. & Madrigal, J. A., Apr 2005, In : Bone Marrow Transplantation. 35, 7, p. 733 - 734 2 p.

    Research output: Contribution to journalLetter

  50. Botulinum toxin: A new dimension in the treatment of lower urinary tract dysfunction.

    Sahai, A., Khan, M. S., Fowler, C. & Dasgupta, P., Jan 2005, In : Urology. 65, 1, p. 211 - 211 1 p.

    Research output: Contribution to journalLetter

  51. A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity

    Apostolidis, A., Dasgupta, R., Fowler, C. J. & Dasgupta, P., 2005, In : BJU International. 96, 6, p. 917 - 918 2 p.

    Research output: Contribution to journalLetter

  52. 2004
  53. Rituximab therapy for the type B syndrome of severe insulin resistance

    Coll, A. P., Thomas, S. & Mufti, G. J., 15 Jan 2004, In : New England Journal of Medicine. 350, 3, p. 310 - 311 2 p.

    Research output: Contribution to journalLetter

  54. Pharmaceutical observership project: An insight into hospital medicine [1]

    Challacombe, B., Salimullah, T. & Dasgupta, P., Jan 2004, In : International Journal of Clinical Practice. 58, 1, p. 103 - 105 3 p.

    Research output: Contribution to journalLetter

  55. 2003
  56. Dose-limiting dermatological toxicity secondary to imatinib mesylate (STI571) in chronic myeloid leukaemia

    Milojkovic, D., Short, K., Salisbury, J. R., Creamer, D., du Vivier, A. W. P. & Mufti, G. J., 1 Jul 2003, In : Leukemia. 17, 7, p. 1414 - 1416 3 p.

    Research output: Contribution to journalLetter

  57. Precipitation of porphyria cutanea tarda by imatinib mesylate?

    Ho, A. Y. L., Deacon, A., Osborne, G. & Mufti, G. J., Apr 2003, In : British Journal of Haematology. 121, 2, p. 375 - 375 1 p.

    Research output: Contribution to journalLetter

  58. Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200

    Ho, A. Y. L., Kenyon, M., El-Hemaidi, L., Devereux, S., Pagliuca, A. & Mufti, G. J., 15 Jan 2003, In : Blood. 101, 2, p. 779 - 780 2 p.

    Research output: Contribution to journalLetter

Previous 1 2 Next

Export:RIS BibTex Word PDF - will at most contain 500 items

Refine results Clear filters

Language

Language

Publication year

Meeting and poster abstracts

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454